Thermo Fisher Scientific Inc (TMO) stock forecast · P/E 24, rev $23.00B
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US. It is led by Marc N. Casper.
This TMO forecast page states what the cached financials imply — not a price target and not a guarantee. Thermo Fisher Scientific Inc outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Period-over-period revenue change is not in cache for TMO, so this page does not invent a growth rate.
TMO currently screens at market cap $153.06B and trailing P/E 23.8. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next TMO 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the TMO stock page.
Not investment advice.